EUSA Pharma initiates study of siltuximab to treat Covid-19 patients
The study will evaluate siltuximab in patients who have developed serious respiratory complications related to Covid-19. Credit: CDC on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more